Alerts will be sent to your verified email
Verify EmailDHARFIN
Dharani Finance
|
Amerise Biosciences
|
Asia Capital
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-0.95 % | -0.9 % | 4.51 % |
5yr average Equity Multiplier
|
1.13 | 1.27 | 1.17 |
5yr Average Asset Turnover Ratio
|
0.08 | 0.15 | 0.09 |
5yr Avg Net Profit Margin
|
-12.02 % | 1.22 % | 41.57 % |
Price to Book
|
0.53 | 0.93 | 0.97 |
P/E
|
5.45 | 97.08 | 16.89 |
5yr Avg Cash Conversion Cycle
|
344.55 Days | 0.0 | 0.0 |
Inventory Days
|
0.0 | 0.0 | 0.0 |
Days Receivable
|
344.55 Days | 0.0 | 0.0 |
Days Payable
|
81.74 Days | 275.57 Days | 0.0 |
5yr Average Interest Coverage Ratio
|
6.22 | -475.34 | 0.0 |
5yr Avg ROCE
|
0.59 % | -0.92 % | 6.11 % |
5yr Avg Operating Profit Margin
|
16.19 % | -0.04 % | 56.18 % |
5 yr average Debt to Equity
|
0.0 | 0.01 | 0.15 |
5yr CAGR Net Profit
|
1.39 % | 0.0 | -2.76 % |
5yr Average Return on Assets
|
-0.9 % | -1.74 % | 3.89 % |
Shareholdings
|
|||
Promoter Holding
|
28.24 % | 0.0 | 75.0 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Dharani Finance
|
Amerise Biosciences
|
Asia Capital
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|